Pregabalin 300 mg or 600 mg vs placeboRisk for at least one adverse event per patient · adults with moderate or severe neuropathic pain1 finding from 1 reviewPregabalin for neuropathic pain in adults 2019 · Cochrane Headline outcomes onlyno estimate extracted15 studies · 3697 participantsHigh